It was found that the presence of CD8+ T cell infiltration and PD-L1 immune cells at baseline is independently associated with better DFS in patients with fully resected, stage IIC-IIIC BRAF V600-mutated melanoma. This evidence concerns the gene BRAF and melanoma.